Amprius Technologies, Inc. (NYSE:AMPX – Get Free Report) Director Wen Hsuan Hsieh sold 413,146 shares of the business’s stock in a transaction dated Thursday, March 12th. The shares were sold at an average price of $18.44, for a total value of $7,618,412.24. Following the sale, the director directly owned 44,444 shares of the company’s stock, valued at approximately $819,547.36. This trade represents a 90.29% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Amprius Technologies Price Performance
Amprius Technologies stock opened at $17.93 on Monday. The stock’s 50-day moving average is $11.88 and its 200-day moving average is $11.12. The company has a market cap of $2.46 billion, a price-to-earnings ratio of -52.72 and a beta of 3.04. Amprius Technologies, Inc. has a 12 month low of $1.80 and a 12 month high of $19.40.
Amprius Technologies (NYSE:AMPX – Get Free Report) last issued its earnings results on Wednesday, March 4th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.03. The business had revenue of $25.23 million during the quarter, compared to analysts’ expectations of $22.91 million. Amprius Technologies had a negative return on equity of 24.29% and a negative net margin of 60.30%.Amprius Technologies has set its FY 2026 guidance at –0.060 EPS. Research analysts anticipate that Amprius Technologies, Inc. will post -0.45 EPS for the current year.
Amprius Technologies News Summary
- Positive Sentiment: Northland Securities raised Q1 EPS estimates for AMPX, improving near-term earnings visibility and giving bulls a fundamental reason to buy. Q1 EPS Estimates for AMPX Increased by Northland Securities
- Positive Sentiment: Needham & Company reaffirmed its Buy rating on AMPX (and other brokers have raised targets or reiterated buys), adding analyst-level validation that can attract institutional and retail inflows. Needham & Company LLC Reaffirms Buy Rating for Amprius Technologies (NYSE:AMPX)
- Neutral Sentiment: Coverage summarizing Northland’s forecast for AMPX Q4 earnings provides modeling context for investors but is informational until tied to company guidance or additional upgrades. What is Northland Securities’ Forecast for AMPX Q4 Earnings?
- Negative Sentiment: Director Steven Chu sold 155,565 shares on March 12 at an average price of $18.50 (~$2.88M), cutting his holdings by roughly 55% — a large insider sale that can be interpreted as a negative signal and may create short-term downward pressure. SEC Filing: Steven Chu Sale (3/12)
- Negative Sentiment: On March 10 the same director sold another 166,632 shares at an average of $17.92 (~$2.99M). The consecutive large sales amplify the negative signaling despite possible non-operational reasons (tax, diversification). SEC Filing: Steven Chu Sale (3/10)
Analysts Set New Price Targets
Several equities research analysts have recently issued reports on the stock. Cantor Fitzgerald increased their price objective on shares of Amprius Technologies from $16.00 to $20.00 and gave the stock an “overweight” rating in a research report on Friday, March 6th. Craig Hallum lifted their target price on shares of Amprius Technologies from $17.00 to $21.00 and gave the company a “buy” rating in a report on Friday, March 6th. Roth Mkm reaffirmed a “buy” rating and set a $20.00 price target (up from $16.00) on shares of Amprius Technologies in a research report on Friday, March 6th. B. Riley Financial increased their price target on Amprius Technologies from $16.00 to $22.00 and gave the company a “buy” rating in a report on Monday, March 9th. Finally, William Blair reissued an “outperform” rating on shares of Amprius Technologies in a research report on Friday, March 6th. Eight research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $19.75.
Read Our Latest Analysis on Amprius Technologies
Institutional Trading of Amprius Technologies
A number of hedge funds have recently made changes to their positions in the company. Bank of America Corp DE lifted its position in shares of Amprius Technologies by 31.1% during the fourth quarter. Bank of America Corp DE now owns 12,890 shares of the company’s stock worth $36,000 after purchasing an additional 3,055 shares in the last quarter. AQR Capital Management LLC grew its holdings in Amprius Technologies by 86.7% during the 1st quarter. AQR Capital Management LLC now owns 77,764 shares of the company’s stock valued at $208,000 after purchasing an additional 36,116 shares in the last quarter. Millennium Management LLC increased its stake in Amprius Technologies by 94.5% during the 1st quarter. Millennium Management LLC now owns 1,396,013 shares of the company’s stock worth $3,741,000 after buying an additional 678,442 shares during the period. Goldman Sachs Group Inc. lifted its holdings in Amprius Technologies by 128.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 244,646 shares of the company’s stock worth $656,000 after buying an additional 137,640 shares in the last quarter. Finally, Rhumbline Advisers lifted its holdings in Amprius Technologies by 61.1% in the 1st quarter. Rhumbline Advisers now owns 15,690 shares of the company’s stock worth $42,000 after buying an additional 5,951 shares in the last quarter. Hedge funds and other institutional investors own 5.04% of the company’s stock.
About Amprius Technologies
Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.
At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.
See Also
- Five stocks we like better than Amprius Technologies
- The $8,000 Gold Call Every Retirement Saver Needs to Read Right Now
- A personal warning from Martin Weiss (Please read)
- Elon Musk: This Could Turn $100 into $100,000
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s gold reserves are priced at $42. The real price is $6,000+.
Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
